Extensive antiarrhythmic drugs after catheter ablation of persistent atrial fibrillation.

Abstract

OBJECTIVE Whether early rhythm suppression with extensive antiarrhythmic drugs (AADs) in persistent atrial fibrillation (AF) after catheter ablation decreases arrhythmia recurrence is unknown. We now report the 12-month follow-up data in this prospective and randomized study. METHODS AND RESULTS 123 consecutive patients with persistent AF undergoing catheter ablation were randomly divided into an extensive AADs therapy group (group 1:62 patients using both class Ic and III AADs) or one AAD therapy group (group 2:61 patients using class Ic or III AADs alone) for the initial 2 months after ablation. Recurrence of atrial tachyarrhythmias (ATa) was valuated at both 2 months and 12 months following ablation. During the first 2 months after ablation, less ATa were found in group 1 compared with group 2 (17/62 versus 29/61, P = 0.021). However, there was no difference with regard to ATa at 12 months between the groups (21/62 versus 22/61, P = 0.799). ATa at 2 months and left atrial diameter (LAD) were the statistically significant predictors of ATa during 12-month follow-up. CONCLUSIONS While use of extensive AADs within the initial 2 months after persistent AF ablation decreases early ATa, it does not prevent late ATa. Moreover, LAD as well as early ATa is a strong predictor of ATa at 12 months.

Cite this paper

@article{Gu2012ExtensiveAD, title={Extensive antiarrhythmic drugs after catheter ablation of persistent atrial fibrillation.}, author={Jun Gu and Xu Liu and Hongwei Tan and Li Zhou and Jianing Gu and Weifeng Jiang and Yuanlong Wang and Yugang Liu}, journal={Acta cardiologica}, year={2012}, volume={67 4}, pages={407-14} }